|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Scientists Who Made Significant Contribution to Discovery of Lantheus Medical Imaging's Cardiolite(R) Honored with Prestigious Nuclear Medicine Award at SNM Annual Meeting
6/15/2009
N. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, congratulates the team of scientists whose research served as the primary foundation for the development of the company’s leading imaging agent, Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), for receiving the SNM’s Georg Charles de Hevesy Nuclear Medicine Pioneer Award. Drs. Michael Abrams, Alan Davison and Alun Jones were presented this prestigious honor for their outstanding contribution to the field of nuclear medicine, specifically their discovery and development of isonitriles, a group of chemical compounds which, when used with the radioisotope technetium-99m, had groundbreaking applications for the field of molecular and nuclear imaging. Dr. Robert Atcher, president of SNM, today presented this award to this group of researchers at the SNM’s 56th Annual Meeting, the world’s largest society for molecular imaging and nuclear medicine professionals, in Toronto.
|
|
|
|
|
|
|
|
|
|
|
|